• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LEMAITRE VASCULAR, INC. XENOSURE BIOLOGICAL PATCH MESH, SURGICAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LEMAITRE VASCULAR, INC. XENOSURE BIOLOGICAL PATCH MESH, SURGICAL Back to Search Results
Catalog Number E0.8P8
Device Problem Insufficient Information (3190)
Patient Problems Abscess (1690); Swelling (2091); Fluid Discharge (2686)
Event Date 10/11/2017
Event Type  Injury  
Manufacturer Narrative
We have not received the patch for evaluation since the patch remains implanted in the patient. Hence, we could not conclusively determine the root cause of the defect. We were notified about this incident through fda ( report no. Mw5073648 ) on (b)(6) 2017 along with other three incidents ( report no. Mw5073649, mw5073661 and mw5073662 ) that occured at this same hospital. After following-up with the hospital, we learned that the culture report was positive for (b)(6) growth. Ct scan on (b)(6) 2017 showed indurated soft tissue thickening at the site without fluid collection. (b)(6) is known to be highly susceptible to destruction from our 0. 2% glutaraldehyde storage solution. Further, our studies have shown that the hardest to sterilize/remove bacteria for our process are the bacillus and clostridium strain for which we have conducted extensive validation work to prove effectiveness of the sterilization process. Our review of the sterilization information for these lots found no abnormalities that would suggest a failure of the process. These facts indicate that these strains could not survive through our sterilization process or storage in the storage solution and indicates that the source of infection is some other cause. (b)(6) is carried by about 2% of the population although most of them aren't infected ( https://www. Cdc. Gov/mrsa/healthcare/index. Htlml). It is possible that the patient got infected with (b)(6) when the surgical wounds were in contact with someone or some surgical instruments during the surgery with exposed (b)(6). We also discovered that it was the same doctor who had performed all four of the patch angioplasty. Doctor do not believe that the patch contributed to the incident. The review of lots history records did not reveal any discrepancies related to the complaint events either during the manufacturing or packaging processes for this lot and had passed all required tests. We have also not received any other complaints from other customers for devices from this lot. Please note that we have also submitted manufacturer report numbers: (b)(4), (b)(4) and (b)(4) for the report no. Mw5073649, mw5073661 and mw5073662, respectively for the other three cases of the infection that occured at the same hospital. Infections can occur in any wound recognizing however that this is a very infrequent occurence for carotid artery surgery. The rate of occurrence for these kinds of incidents has remained very low (0. 001%). The fact that the organisms differ in each of the specimens in each cases also indicates that the infection was from an external source or carrier. While the root cause(s) of this incident remains inconclusive, we do believe that it is highly unlikely that the xenosure patch contributed to the incident.
 
Event Description
Patient underwent left carotid endarterectomy with patch angioplasty on (b)(6) 2017. Patient complained about lump on the side of the neck at the site of patch implant and returned to the hospital on (b)(6) 2017. Oral antibiotics was prescribed and patient was sent home. During follow-up on (b)(6) 2017, superficial abscess was observed. Incision and drainage was performed. Boil was observed on distal incision on the day of i&d. Small 1. 5 cm x 1. 5 cm fluid was collected between the two incisions.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand NameXENOSURE BIOLOGICAL PATCH
Type of DeviceMESH, SURGICAL
Manufacturer (Section D)
LEMAITRE VASCULAR, INC.
63 second ave
burlington MA 01803
Manufacturer (Section G)
LEMAITRE VASCULAR, INC.
63 second ave
burlington MA 01803
Manufacturer Contact
pragya thikey
63 second ave
burlington, MA 01803
7812212266
MDR Report Key7204767
MDR Text Key97721778
Report Number1220948-2018-00002
Device Sequence Number1
Product Code FTM
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K040835
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation
Type of Report Initial
Report Date 01/17/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/18/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator
Device Catalogue NumberE0.8P8
Device Lot NumberXBU2460
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Event Location No Information
Date Manufacturer Received12/19/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/15/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial

Patient Treatment Data
Date Received: 01/18/2018 Patient Sequence Number: 1
-
-